Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11774452 Antibodies against carcinoembryonic antigens

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Özge Alper

Date of Patent

October 3, 2023

Patent Application Number

18164206

Date Filed

February 3, 2023

Patent Citations

US Patent 7371826 Polypeptide variants with altered effector function

US Patent 7521541 Cysteine engineered antibodies and conjugates

US Patent 7125978 Promoter for regulating expression of foreign genes

US Patent 7332581 Polypeptide variants with altered effector function

Patent Primary Examiner

Robert S. Landsman

CPC Code

Patent abstract

The invention provides an anti-CEA antibody for use in detecting CEA, treating disorders associated with CEA expression, diagnosing cancers characterized by aberrant CEA expression, and predicting effectiveness of cancer drug therapies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11774452 Antibodies against carcinoembryonic antigens

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool